Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    19556517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine
Conditions: Pneumococcal Pneumonia;   Influenza
Interventions: Biological: Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®;   Biological: Sequential administration of Pneumovax NP® and Fluvic HA syringe®
2 Completed
Has Results
Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Biological: Pneumovax (PPSV23);   Biological: Prevnar (PCV7)

Indicates status has not been verified in more than two years